The mechanism of these effects may be partly mediated by AGEs-RAGE-ROS pathway via the interaction with Glp1r. This may provide benefits to therapy with liraglutide on diabetic osteoporosis as it could work as an agent against the AGEs–RAGE axis and may play a protective role against osteoporosis in diabetes. This evidence concerns the gene GLP1R and osteoporosis.